What are the responsibilities and job description for the Sr. Executive Assistant and Office Manager position at Solu Therapeutics?
Sr. Executive Assistant & Office Manager
Solu Therapeutics is seeking a highly organized and proactive Senior Executive Assistant & Office Manager to provide comprehensive support to senior leadership and ensure the smooth running of our office operations. Reporting directly to the Chief Executive Officer, this dual office-based role requires a dynamic individual who can effectively balance executive support, office management and team coordination, contributing to the overall efficiency of the organization.
Key Responsibilities
Executive Administration :
Core Responsibilities
- Provide high level administrative support for all aspects of CEO responsibilities, including proactively managing complex calendar, travel and hotel arrangements, expense reports, meeting and conference support.
- Organize in-house and off-site senior meetings such as Board Meetings, CEO meetings with board members, and SAB Meetings. Responsibilities include handling logistics, materials, correspondence with attendees and coordination of overall meeting / event.
- For external meetings involving multiple senior leaders (eg conferences), ensure coordination of travel and hotel arrangements.
- Preparations for Board of Directors Meetings including arrangements for hotels, travel, meals, cars, etc. Work with CEO to ensure consistent formatting of board materials. Coordinate with IT that all equipment is ready prior to meeting.
- Coordinate meetings between CEO and investors not on the board
- Organize and maintain confidential information.
Additional Responsibilities
Office Management :
Qualifications :
Interested applicants should email resume to hr@solutherapeutics.com
About Us :
At Solu, our mission is to develop a new generation of medicines that transform patient lives. Solu Therapeutics was established in May 2023 following the granting of an exclusive license to the CyTACTM platform from GSK. Our lead CyTAC program is planned to enter the clinic in early 2025, with a number of exciting CyTAC and TicTACTM programs advancing to development candidate status. Solu Therapeutics is headquarted at Lilly Gateway Labs in Boston MA.